Implementation Guidelines - Federal Transit Administration - U.S. ...
Implementation Guidelines - Federal Transit Administration - U.S. ... Implementation Guidelines - Federal Transit Administration - U.S. ...
Privacy Act Statement: (For Federal Employees Only) Submission of the information on the attached form is voluntary. However, incomplete submission of the information, refusal to provide a urine specimen, or substitution, or adulteration of a specimen may result in a delay or denial of your application for employment/appointment or may result in removal from the Federal service or other disciplinary action. The authority for obtaining the urine specimen and identifying information contained herein is Executive Order 12564 (“Drug-Free Federal Workplace”), 5 U.S.C § 3301 (2) 5 U.S.C § 7301, and Section 503 of Public Law 100-71, 5 U.S.C § 7301 note. Under provisions of Executive Order 12564 and 5 U.S.C. 7301, test results may only be disclosed to agency officials on a needto-know basis. This may include the agency Medical Review Officer, the administrator of the Employee Assistance Program, and a supervisor with authority to take adverse personnel action. This information may also be disclosed to a court where necessary to defend against a challenge to an adverse personnel action. Submission of your SSN is not required by law and is voluntary. Your refusal to furnish your number will not result in the denial of any right, benefit, or privilege provided by law. Your SSN is solicited, pursuant to Executive Order 9397, for urinalysis testing for illegal drugs. If you refuse to indicate your SSN, a substitute number or other identifier will be assigned as required, to process the specimen. In the event laboratory analysis determines the presence of one or more illegal drugs in the specimen you provide, you will be contacted by an agency Medical Review Officer (MRO). The MRO will determine whether there is a legitimate medical explanation for the drug(s) identified by urinalysis. Paperwork Reduction Act Notice (as required by 5 CFR 1320.21) Public reporting burden for this collection of information, including the time for reviewing instructions, gathering and maintaining the data needed, and completing and reviewing the collection of information is estimated for each respondent to average: 5 minutes/donor; 4 minutes/collector; 3 minutes/laboratory; and 3 minutes/Medical Review Officer. Federal Employees may send comments regarding these burden estimates, or any other aspect of this collection of information including suggestion for reducing the burden to the SAMHSA Reports Clearance Officer, Paperwork Reduction Project (0930-0158), Room 16-105, Parklawn Building, 5600 Fishers Lane, Rockville, MD 20857. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The OMB control number for this project is 0930-0158. Chapter 7. Drug Testing Procedures 7-41 August 2002
Chapter 8. ALCOHOL TESTING PROCEDURES The FTA regulation (49 CFR Part 655) requires that you conduct breath alcohol testing on safety-sensitive employees consistent with 49 CFR Part 40, Subparts J through N. The alcohol test consists of an initial screen test, that if not negative, is followed by a confirmatory test. A breath alcohol test measures the alcohol in a volume of breath expressed in terms of grams of alcohol per 210 liters of breath. Alcohol is the intoxicating agent in beverage alcohol, ethyl alcohol, or other low molecular weight alcohols. The test measures the concentration of alcohol regardless of its source. Thus, it will detect alcohol consumed as a beverage, candy, food, medicine, or other product where the quantity of alcohol results in a breath alcohol concentration above the minimum cut-off levels. Only saliva and breath tests using approved devices are authorized by the DOT for alcohol screen tests, and only breath tests are authorized for confirmatory alcohol tests. Urine and blood tests are not allowed for DOT covered alcohol tests. The FTA regulation (§40.23) prohibits any employer from allowing an employee with an alcohol concentration of 0.04 or greater to perform any safety-sensitive duties until he/she has been evaluated by an SAP and has passed a return-to-duty test. An employee with an alcohol concentration of 0.02 or greater, but less than 0.04, must be removed from duty for 8 hours or until a retest shows an alcohol concentration of less than 0.02. Section 1. ALCOHOL TESTING DEVICES The initial screen test may be conducted using an evidential breath testing device (EBT) or a non-evidential alcohol screen device (ASD) using breath or saliva. The confirmatory test can only be conducted using an EBT. Alcohol Screen Devices (ASD) (§40.3). An ASD is a breath or saliva device, other Chapter 8. Alcohol Testing Procedures 8-1 August 2002
- Page 107 and 108: 1. Determine how frequently random
- Page 109 and 110: In many small transit systems, ever
- Page 111 and 112: Before making the return-to-duty re
- Page 113 and 114: up testing program. The SAP must do
- Page 115 and 116: Employee Discharged BAC >= 0.04 Con
- Page 117 and 118: Employee Discharged Split Specimen
- Page 119 and 120: Sample Documentation Chapter 6. Typ
- Page 121 and 122: 1) Accident Report Number: 2) Locat
- Page 123 and 124: Chapter 7. DRUG TESTING PROCEDURES
- Page 125 and 126: Recommendation Multiple Collection
- Page 127 and 128: spouse, relative) or a close person
- Page 129 and 130: The DOT requires the new version of
- Page 131 and 132: 9. The collector must direct the em
- Page 133 and 134: evening contact telephone numbers i
- Page 135 and 136: temperature range (90.0 to 100.0 F)
- Page 137 and 138: publishes its final rule establishi
- Page 139 and 140: for the preceding 6 months ending o
- Page 141 and 142: Chapter 7. Drug Testing Procedures
- Page 143 and 144: • The MRO will verify the test re
- Page 145 and 146: The MRO may change a verified test
- Page 147 and 148: direct the DER to have the employee
- Page 149 and 150: employee for a retest under direct
- Page 151 and 152: Sample Documentation Chapter 7. Dru
- Page 153 and 154: Collection Site Checklist (cont.) (
- Page 155 and 156: 12. You may now wash your hands and
- Page 164 and 165: than an EBT, that is approved by th
- Page 166 and 167: Breath Alcohol Technician (§40.213
- Page 168 and 169: availability and the need for backu
- Page 170 and 171: At the conclusion of the screen tes
- Page 172 and 173: sufficient amount of breath. A medi
- Page 174 and 175: In addition to stipulating the cons
- Page 176 and 177: Sample Documentation Chapter 8. Alc
- Page 178 and 179: [Federal Register: May 4, 2001 (Vol
- Page 180 and 181: The Conforming Products List is the
- Page 182 and 183: Highway Safety Programs; Model Spec
- Page 184 and 185: 45420 Federal Register / Vol. 65, N
- Page 186 and 187: 45422 Federal Register / Vol. 65, N
- Page 188: U.S. Department of Transportation (
- Page 194 and 195: Section 1. SAP QUALIFICATIONS A sub
- Page 196 and 197: Education/Treatment Program Referra
- Page 198 and 199: Employers are not required to follo
- Page 200 and 201: SAP, many employers have looked to
- Page 202 and 203: 10 weeks, with most sessions schedu
- Page 204 and 205: _____________________________ _____
- Page 206 and 207: FOLLOW-UP TESTING PROCESS SAP Input
Privacy Act Statement: (For <strong>Federal</strong> Employees Only)<br />
Submission of the information on the attached form is voluntary. However, incomplete<br />
submission of the information, refusal to provide a urine specimen, or substitution, or<br />
adulteration of a specimen may result in a delay or denial of your application for<br />
employment/appointment or may result in removal from the <strong>Federal</strong> service or other disciplinary<br />
action.<br />
The authority for obtaining the urine specimen and identifying information contained herein<br />
is Executive Order 12564 (“Drug-Free <strong>Federal</strong> Workplace”), 5 U.S.C § 3301 (2) 5 U.S.C § 7301,<br />
and Section 503 of Public Law 100-71, 5 U.S.C § 7301 note. Under provisions of Executive<br />
Order 12564 and 5 U.S.C. 7301, test results may only be disclosed to agency officials on a needto-know<br />
basis. This may include the agency Medical Review Officer, the administrator of the<br />
Employee Assistance Program, and a supervisor with authority to take adverse personnel action.<br />
This information may also be disclosed to a court where necessary to defend against a challenge<br />
to an adverse personnel action.<br />
Submission of your SSN is not required by law and is voluntary. Your refusal to furnish<br />
your number will not result in the denial of any right, benefit, or privilege provided by law.<br />
Your SSN is solicited, pursuant to Executive Order 9397, for urinalysis testing for illegal drugs.<br />
If you refuse to indicate your SSN, a substitute number or other identifier will be assigned as<br />
required, to process the specimen.<br />
In the event laboratory analysis determines the presence of one or more illegal drugs in the<br />
specimen you provide, you will be contacted by an agency Medical Review Officer (MRO). The<br />
MRO will determine whether there is a legitimate medical explanation for the drug(s) identified<br />
by urinalysis.<br />
Paperwork Reduction Act Notice (as required by 5 CFR 1320.21)<br />
Public reporting burden for this collection of information, including the time for reviewing<br />
instructions, gathering and maintaining the data needed, and completing and reviewing the<br />
collection of information is estimated for each respondent to average: 5 minutes/donor; 4<br />
minutes/collector; 3 minutes/laboratory; and 3 minutes/Medical Review Officer. <strong>Federal</strong><br />
Employees may send comments regarding these burden estimates, or any other aspect of this<br />
collection of information including suggestion for reducing the burden to the SAMHSA Reports<br />
Clearance Officer, Paperwork Reduction Project (0930-0158), Room 16-105, Parklawn Building,<br />
5600 Fishers Lane, Rockville, MD 20857. An agency may not conduct or sponsor, and a person<br />
is not required to respond to, a collection of information unless it displays a currently valid OMB<br />
control number. The OMB control number for this project is 0930-0158.<br />
Chapter 7. Drug Testing Procedures 7-41 August 2002